BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190702
DTEND;VALUE=DATE:20190805
DTSTAMP:20260729T211204
CREATED:20190702T170150Z
LAST-MODIFIED:20190702T170418Z
UID:21319-1562025600-1564963199@ces.b2sg.org
SUMMARY:Research Opportunities - Medical Oncology
DESCRIPTION:There is an opportunity for research in the laboratory of Dr. Jieya Shao. The central theme of the lab is unravelling novel cancer biology with the overarching goal of developing effective therapies. Two main projects are currently ongoing primarily in the context of breast cancer: \n1. “Moonlighting” functions of the actin-binding protein profilin-1 (Pfn1) in transcriptional and epigenetic regulation. As an essential eukaryotic protein\, the mechanisms behind the paradoxical anticancer effects of profilin-1 have remained mysterious for nearly two decades. Our recent studies suggest that the anticancer activities of Pfn1 may stem from its poorly understood nuclear functions which become deregulated in cancer due to an alteration of its nucleocytoplasmic trafficking. We are currently focusing on defining its novel roles in transcriptional control and epigenetic regulation in the context of both estrogen receptor positive and triple negative breast cancer by utilizing multidisciplinary approaches including biochemistry\, molecular and cellular biology\, proteomics\, mouse xenograft models\, and next generation sequencing.\n2. The role of VCP in protein homeostasis\, DNA damage response\, and chemotherapy efficacy of cancer. Valosin-containing protein (VCP) is an evolutionarily conserved and highly abundant AAA+ ATPase involved in diverse cellular processes. Functioning as a “segregase”\, VCP maintains protein homeostasis by extracting polyubiquitinated proteins from various cellular locations or complexes for turnover. Numerous studies have now linked VCP to chromatin-associated protein degradation and genome stability maintenance particularly in the context of DNA damage response. Nevertheless\, detailed understanding of its mechanism of action\, its mode of (de)regulation in cancer\, and its relevance to chemotherapy response is lacking\, and we are currently investigating all these questions. \n\n\nPreferred Qualifications\n\n\n\n\n\n\n\n\nCandidates with general understanding of biochemistry\, molecular and cellular biology and prior experience in mammalian cell culture\, Western blotting\, DNA/RNA isolation\, mouse handling and surgery are preferred.\nKnowledge in genetics/epigenetics and experience in quantitative PCR and chromatin immunoprecipitation (ChIP) is a plus\, so is the skill in data mining and computational analysis.\nMust have troubleshooting skills\, independent analytical thinking and research planning skills.\nDemonstrated ability to work independently and communicate with the laboratory staff and investigators.\nAbility to maintain complete and organized records/reports.\nWorking knowledge of computer software and general lab equipment.
URL:https://ces.b2sg.org/event/2jul19/
LOCATION:Washington University in St. Louis\, 1 Brookings Dr.\, St. Louis\, MO\, 63130\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2019/07/washington-university-in-st-louis-logo-no-background-e1562087037569.jpg
END:VEVENT
END:VCALENDAR